Predictable & Repeatable
Clinical Research with Kindness

Advancing science with compassion — where every study begins with care for our patients

Discover the Rovia Research Experience

Rapid Study
Start-Up

Dedicated centralized teams that streamline activation and prioritize rapid first patient enrollment across the network.

Enrollment, Retention & Diversity Promise

Experience the kinder side of research through compassionate care, flexible scheduling, and accessible locations across diverse communities. With 18 sites, patient-centered physicians, and 100% patient satisfaction, we make every participant feel heard, respected, and valued.

Quality Guarantee

Patient safety is our top priority. Our centralized oversight, reliable SOPs, and timely data practices help ensure consistent, compliant, and high-quality study execution across every site.

Rovia at a Glance

Rovia is a U.S.-based network of wholly owned research sites with direct EMR access through strong community physician partnerships. We are built to support rapid study start-up, enrollment target achievement, and consistent, high-quality study execution.

U.S. Research Sites
U.S. Research Sites
18

7 States

Mississippi

Georgia

Lousiana

Florida

Missouri

Tennessee

North Carolina

 

Patient Access
Patient Access
EMR Patients in diverse communities
1 M+

Core
Therapeutic Areas

Metabolic

Cardiology

Endocrinology

Neurology

Psychiatry

Opthalmology

Infectious Disease

Gastroenterology

Patient Reviews

Delivering Speed, Quality, and Diversity in Clinical Research

Major global pharmas, biotechs and CROs partner with Rovia to reliably execute fast study start-up, patient enrollment, and high-quality data delivery, while providing access to diverse patient populations. Our large centralized teams, combined with deep localized expertise, enable us to consistently meet and exceed partner expectations through efficient study start-up, accelerated timelines, strong enrollment performance, and high patient retention.

Rovia investigators play a critical role in optimizing the research experience—including in study design, in protocols, and in performance—and remain actively engaged at every stage. If you’re looking for a partner who can deliver both speed and quality at scale, consider partnering with Rovia for your next study.

Study Start-up Service Level Expectations

check-icon

Regulatory
Submission

Patients Enrolled

< 5 Days
contract-icon
Confidential Disclosure
Agreement (CDA)
Confidential Disclosure Agreements
48 Hours

Feasibility
Completed

Feasibility

72 Hours
signed-contract-icon

CTA
(received to executed)

Completed Studies

< 30 Days

Sponsor Reviews